Lexeo Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lexeo Therapeutics Inc
TickerLXEO
CIK #0001907108
CUSIP52886X107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address345 Park Avenue South Floor 6, New York, NY 10010
Source [EDGAR]
CIK Filing 2011 - 2024
[0001907108] 10-K
[0001907108] 10-Q
[0001907108] 3
[0001907108] 4
[0001907108] 8-K
[0001907108] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Lundbeckfond Invest A/S Lexeo Therapeutics Inc [2024-02-14] 6.9
Janus Henderson Group PLC Lexeo Therapeutics Inc [2024-02-14] 8.7
Omega Fund VI LP Lexeo Therapeutics Inc [2024-02-14] 81948.1
D1 Capital Partners LP Lexeo Therapeutics Inc [2024-02-14] 0.4
Longitude Capital Partners IV LLC Lexeo Therapeutics Inc [2024-02-13] 81949.6
Eventide Asset Management LLC Lexeo Therapeutics Inc [2023-12-11] 11.93
Novo Holdings A/S Lexeo Therapeutics Inc [2023-11-24] 5.1
Citadel Advisors LLC Lexeo Therapeutics Inc [2023-11-17] 8.3
Form 3/4/5 Filer 2011 - 2024
Townsend Richard Nolan
Lexeo Therapeutics, Inc.
Van Hauwermeiren Timothy
Cholmondeley Paula H
Cooperstone Brenda
Altschuler Steven
Diaz Reinaldo M
Agger Mette Kirstine
Otero Jose Manuel
Adler Eric
See Tai Sandi
Robertson Jenny
McCormac Paul
Omega Fund VI GP, L.P.
Paster Anne-Mari
Nessi Claudio
Stampacchia Otello
Omega Fund VI, L.P.
Omega Fund VI GP Manager, Ltd.
Lundbeckfond Invest A/S
Tammenoms Bakker Juliet
Enright Patrick G
Longitude Venture Partners IV, L.P.
Longitude Capital Partners IV, LLC
Davitian Bernard
Form 13F Holdings
Firm Period DFND Voting Shares
Eventide Asset Management LLC [2024-06-30] SOLE 3,369,147.0 3,369,147.0
Janus Henderson Group PLC [2024-06-30] DFND 0.0 3,163,992.0
Adage Capital Partners GP LLC [2024-06-30] SOLE 2,597,736.0 2,597,736.0
Citadel Advisors LLC [2024-06-30] DFND 2,558,611.0 2,558,611.0
D1 Capital Partners LP [2024-06-30] SOLE 2,506,607.0 2,506,607.0
Omega Fund Management LLC [2024-06-30] SOLE 2,355,904.0 2,355,904.0
Novo Holdings A/S [2024-06-30] SOLE 1,450,500.0 1,450,500.0
Braidwell LP [2024-06-30] SOLE 1,382,481.0 1,382,481.0
Vestal Point Capital LP [2024-06-30] SOLE 840,000.0 840,000.0
Woodline Partners LP [2024-06-30] SOLE 824,074.0 824,074.0
Blackstone Inc. [2024-06-30] OTR 0.0 805,757.0
BlackRock Finance, Inc. [2024-06-30] SOLE 781,346.0 791,584.0
RA Capital Management LP [2024-06-30] SOLE 672,712.0 672,712.0
Vanguard Group Inc [2024-06-30] SOLE 0.0 605,311.0
Artal Group S.A. [2024-06-30] DFND 603,435.0 603,435.0
Laurion Capital Management LP [2024-06-30] SOLE 453,582.0 453,582.0
Verition Fund Management LLC [2024-06-30] SOLE 421,392.0 421,392.0
Geode Capital Management LLC [2024-06-30] DFND 296,612.0 296,612.0
State Street Corp [2024-06-30] DFND 188,335.0 196,272.0
Tudor Investment Corp ET AL [2024-06-30] DFND 132,187.0 132,187.0
Northern Trust Corp [2024-06-30] DFND 343.0 94,907.0
Polar Asset Management Partners Inc [2024-06-30] SOLE 65,300.0 65,300.0
Millennium Management LLC [2024-06-30] SOLE 37,466.0 37,466.0
Bank of New York Mellon Corp [2024-06-30] DFND 28,633.0 31,806.0
Charles Schwab Investment Management Inc [2024-06-30] SOLE 30,861.0 30,861.0
Goldman Sachs Group Inc [2024-06-30] DFND 26,853.0 26,853.0
Jane Street Group LLC [2024-06-30] DFND 26,759.0 26,759.0
Vanguard Group Inc [2024-06-30] DFND 0.0 24,608.0
Wellington Management Group LLP [2024-06-30] DFND 0.0 22,101.0
Barclays PLC [2024-06-30] SOLE 19,153.0 19,153.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com